ReCode Therapeutics
Developer of targeted delivery technology designed for patients with rare diseases. The company's platform utilizes lipid nanoparticles to precisely deliver corrective or disease-modifying genetic the...
Valuation
$0
Share Price
N/A
Total Raised
$388M
Last Round
N/A